Signal active
Bio
Bob Pettigrew has more than 30 years experience in the development of emerging businesses. In 1986 he co-founded Generics (aka Sagentia Plc) and was key member of the team that took the company public in December 2000.
He is an investor director on the board of a number of technology companies including Odos Ltd., Nightingale-EOS Ltd. and Sunamp Ltd. He was Chairman of Voxar Ltd and managed its $50m trade sale in Sept 2004 and served previously as NXD with Oxonica, Sphere Medical Plc., Zinwave Ltd., and Digital Health Care Ltd.
He is a member of the advisory board of Ascendant Corporate Finance as well as being a non executive board member of British Small Companies VCT2 Plc.
Location
N/A
Social
Primary Organization
2005
1-10
Information Technology, Health Care, Manufacturing
Jobs history
0
N/A
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
Bob Pettigrew is the Investor Director at Nightingale-EOS Ltd, based in Europe. With a background in Information Technology, Bob Pettigrew has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Investment portfolio
1
0
Personal investment
1
Annouced Date | Organization Name | Funding Round | Money Raised |
---|---|---|---|
Apr 30, 2019 | DevicePilot | Seed Round - DevicePilot | 1.8M |
Partner investment
0
There is no partner investment available on this profile
Exits
0
There is no exit available on this Profile
Invest in industries
Recent Activity
There is no recent news or activity for this profile.